Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
– Apraglutide nutritional data from STARS Nutrition Phase 2 study in adult patients who have short bowel syndrome with intestinal failure and colon-in-continuity... Read more.
Vecima Announces Turnkey DAA Packages with RocNet Supply, Speeding 10G Deployments for Smaller Operators
VICTORIA, British Columbia–(BUSINESS WIRE)–Vecima Networks Inc. (TSX: VCM) today announced a partnership with RocNet Supply to offer turnkey Distributed... Read more.
Tellurian Reports 2023 Financial Results and Driftwood LNG Progress
HOUSTON–(BUSINESS WIRE)–Tellurian Inc. (Tellurian or the Company) (NYSE American: TELL) reported its full year 2023 financial results today. During 2023,... Read more.
Popular, Inc. Declares a Cash Dividend of $0.62 per Common Share
SAN JUAN, Puerto Rico–(BUSINESS WIRE)–Popular, Inc. (NASDAQ: BPOP) announced today that its Board of Directors has approved a quarterly cash dividend... Read more.
Global IV Catheters Market Insights Report 2023-2029: Peripheral Inserted Central Catheters (PICCs) Leading the Charge – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global IV Catheters Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s... Read more.
Missouri Office of Broadband Development Launches Interactive Map Using Sanborn’s Broadband Navigator™ Technology
COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–The Missouri Department of Economic Development’s (DED) Office of Broadband Development (OBD) has launched... Read more.
Immunis Chairman Dr. Hans Keirstead is an Invited Speaker at the 2024 Brain Trust Conference
IRVINE, Calif.–(BUSINESS WIRE)–#ClinicalTrials—Immunis, Inc., a private biotech company revolutionizing cellular secretome therapeutics, is proud... Read more.
Global Home Energy Management System Market Outlook Report 2023-2029 – Growth in Demand for Smart Energy Monitoring in Sustainable Buildings – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Home Energy Management System Market – Outlook & Forecast 2024-2029” report has been added to... Read more.
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
CARVYKTI® is the first CAR-T therapy for patients with relapsed and refractory multiple myeloma to receive a positive CHMP opinion for second line treatment SOMERSET,... Read more.
Vertex Receives CHMP Positive Opinion for KALYDECO® for the Treatment of Infants With Cystic Fibrosis Ages 1 Month and Older
– If approved, KALYDECO® will be the first and only medicine approved in Europe to treat the underlying cause of cystic fibrosis in babies as young as 1 month... Read more.